These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Five-year outcomes following timely primary percutaneous intervention, late primary percutaneous intervention, or a pharmaco-invasive strategy in ST-segment elevation myocardial infarction: the FAST-MI programme. Danchin N; Popovic B; Puymirat E; Goldstein P; Belle L; Cayla G; Roubille F; Lemesle G; Ferrières J; Schiele F; Simon T; Eur Heart J; 2020 Feb; 41(7):858-866. PubMed ID: 31539043 [TBL] [Abstract][Full Text] [Related]
3. Five-year survival in patients with ST-segment-elevation myocardial infarction according to modalities of reperfusion therapy: the French Registry on Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) 2005 Cohort. Danchin N; Puymirat E; Steg PG; Goldstein P; Schiele F; Belle L; Cottin Y; Fajadet J; Khalife K; Coste P; Ferrières J; Simon T; Circulation; 2014 Apr; 129(16):1629-36. PubMed ID: 24657993 [TBL] [Abstract][Full Text] [Related]
4. System delay and timing of intervention in acute myocardial infarction (from the Danish Acute Myocardial Infarction-2 [DANAMI-2] trial). Nielsen PH; Terkelsen CJ; Nielsen TT; Thuesen L; Krusell LR; Thayssen P; Kelbaek H; Abildgaard U; Villadsen AB; Andersen HR; Maeng M; Am J Cardiol; 2011 Sep; 108(6):776-81. PubMed ID: 21757183 [TBL] [Abstract][Full Text] [Related]
5. Long-term prognostic value of ST-segment resolution in patients treated with fibrinolysis or primary percutaneous coronary intervention results from the DANAMI-2 (DANish trial in acute myocardial infarction-2). Sejersten M; Valeur N; Grande P; Nielsen TT; Clemmensen P; J Am Coll Cardiol; 2009 Nov; 54(19):1763-9. PubMed ID: 19874989 [TBL] [Abstract][Full Text] [Related]
6. Fibrinolysis use among patients requiring interhospital transfer for ST-segment elevation myocardial infarction care: a report from the US National Cardiovascular Data Registry. Vora AN; Holmes DN; Rokos I; Roe MT; Granger CB; French WJ; Antman E; Henry TD; Thomas L; Bates ER; Wang TY JAMA Intern Med; 2015 Feb; 175(2):207-15. PubMed ID: 25485876 [TBL] [Abstract][Full Text] [Related]
7. Does diabetes mellitus abolish the beneficial effect of primary coronary angioplasty on long-term risk of reinfarction after acute ST-segment elevation myocardial infarction compared with fibrinolysis? (A DANAMI-2 substudy). Madsen MM; Busk M; Søndergaard HM; Bøttcher M; Mortensen LS; Andersen HR; Nielsen TT; Am J Cardiol; 2005 Dec; 96(11):1469-75. PubMed ID: 16310424 [TBL] [Abstract][Full Text] [Related]
8. Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy. Maeng M; Nielsen PH; Busk M; Mortensen LS; Kristensen SD; Nielsen TT; Andersen HR; Am J Cardiol; 2010 Jun; 105(11):1528-34. PubMed ID: 20494656 [TBL] [Abstract][Full Text] [Related]
9. Rationale and design of the OPTIMAL-REPERFUSION trial: A prospective randomized multi-center clinical trial comparing different fibrinolysis-transfer percutaneous coronary intervention strategies in acute ST-segment elevation myocardial infarction. Chen Z; Wang D; Ma M; Li C; Wan Z; Zhang L; Zhu Y; Wang M; Wang H; He S; Peng Y; Wei J; Huang B; He Y; Clin Cardiol; 2021 Apr; 44(4):455-462. PubMed ID: 33634478 [TBL] [Abstract][Full Text] [Related]
10. Primary angioplasty versus fibrinolysis in acute myocardial infarction: long-term follow-up in the Danish acute myocardial infarction 2 trial. Nielsen PH; Maeng M; Busk M; Mortensen LS; Kristensen SD; Nielsen TT; Andersen HR; Circulation; 2010 Apr; 121(13):1484-91. PubMed ID: 20308618 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction). Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B; Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990 [TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of non-compliance with guidelines-recommended times to reperfusion therapy in ST-elevation myocardial infarction. The FAST-MI 2010 registry. Puymirat E; Caudron J; Steg PG; Lemesle G; Cottin Y; Coste P; Schiele F; de Labriolle A; Bataille V; Ferrières J; Simon T; Danchin N; Eur Heart J Acute Cardiovasc Care; 2017 Feb; 6(1):26-33. PubMed ID: 26450784 [TBL] [Abstract][Full Text] [Related]
14. Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study. Farag M; Spinthakis N; Gue YX; Srinivasan M; Sullivan K; Wellsted D; Gorog DA Eur Heart J; 2019 Jan; 40(3):295-305. PubMed ID: 30380032 [TBL] [Abstract][Full Text] [Related]
15. Role of ST-Segment Resolution in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (from the 5-Year Outcomes of the EXAMINATION [Evaluation of the Xience-V Stent in Acute Myocardial Infarction] Trial). Spitaleri G; Brugaletta S; Scalone G; Moscarella E; Ortega-Paz L; Pernigotti A; Gomez-Lara J; Cequier A; Iñiguez A; Serra A; Jiménez-Quevedo P; Mainar V; Campo G; Tespili M; den Heijer P; Bethencourt A; Vazquez N; Valgimigli M; Serruys PW; Sabaté M Am J Cardiol; 2018 May; 121(9):1039-1045. PubMed ID: 29544865 [TBL] [Abstract][Full Text] [Related]
16. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis. Sim DS; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ; Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582112 [TBL] [Abstract][Full Text] [Related]
17. Fibrinolysis versus primary percutaneous intervention in ST-elevation myocardial infarction with long interhospital transfer distances. Beri A; Printz M; Hassan A; Babb JD Clin Cardiol; 2010 Mar; 33(3):162-7. PubMed ID: 20235202 [TBL] [Abstract][Full Text] [Related]
18. Comparison of 30-day mortality and myocardial scar indices for patients treated with prehospital reduced dose fibrinolytic followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction. Solhpour A; Chang KW; Arain SA; Balan P; Zhao Y; Loghin C; McCarthy JJ; Vernon Anderson H; Smalling RW Catheter Cardiovasc Interv; 2016 Nov; 88(5):709-715. PubMed ID: 27028120 [TBL] [Abstract][Full Text] [Related]
19. ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-year mortality follow-up. Sinnaeve PR; Armstrong PW; Gershlick AH; Goldstein P; Wilcox R; Lambert Y; Danays T; Soulat L; Halvorsen S; Ortiz FR; Vandenberghe K; Regelin A; Bluhmki E; Bogaerts K; Van de Werf F; Circulation; 2014 Sep; 130(14):1139-45. PubMed ID: 25161043 [TBL] [Abstract][Full Text] [Related]
20. Outcome up to one year following different reperfusion strategies in acute ST-segment elevation myocardial infarction: the Helsinki-Uusimaa Hospital District registry of ST-Elevation Acute Myocardial Infarction (HUS-STEMI). Viikilä J; Lilleberg J; Tierala I; Syvänne M; Kupari M; Salomaa V; Nieminen MS; Eur Heart J Acute Cardiovasc Care; 2013 Dec; 2(4):371-8. PubMed ID: 24338296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]